New guidelines have been produced for the management of primary biliary cholangitis, an infrequent but nonetheless important autoimmune liver disease. We provide a succient commentary and overview of the key features of disease management that arise from these recent guideline recommendations, with a focus on therapy with licensed agents (ursodeoxycholic acid and obeticholic acid) as well as personalised management of disease complications and associated symptoms.

Additional Metadata
Persistent URL dx.doi.org/10.1136/flgastro-2018-101109, hdl.handle.net/1765/117833
Journal Frontline Gastroenterology
Citation
Goet, J.C., & Hirschfield, G.M. (2019). Guideline review: British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis treatment and management guidelines. Frontline Gastroenterology, 10(3), 316–319. doi:10.1136/flgastro-2018-101109